Complete Blood Count-Derived Inflammatory Indices and Systemic Inflammatory Burden in Children with Rheumatic Manifestations Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection or Exposure: A Retrospective Study
Abstract
Introduction. Rheumatic, vascular, musculoskeletal, and systemic inflammatory manifestations have been described in children after SARS-CoV-2 infection. Indices derived from the complete blood count may reflect systemic inflammatory burden without additional blood sampling or laboratory cost. The aim of the study. To investigate the associations between complete blood count-derived inflammatory indices and systemic inflammatory burden in children with rheumatic manifestations following coronavirus disease 2019 infection or exposure, and to explore their associations with corticosteroid treatment, prolonged hospitalization, and relapse. Materials and methods. A retrospective single-center study included the data of 68 children under 18 years of age, examined between March 2020 and March 2025. Indices were determined based on complete blood count values obtained before the administration of corticosteroids or other immunomodulatory therapy. After quality control, 65 patients were included in the analysis of indices determined on the basis of complete blood count. Associations with C-reactive protein, erythrocyte sedimentation rate, ferritin, and D-dimer were assessed using Spearman rank correlation with J. Benjamini-J. Hochberg correction. Additionally, age-adjusted analysis, receiver operating characteristic curve analysis, and exploratory logistic regression were performed. Results. AISI, SIRI, and SII showed the most consistent correlations with conventional inflammatory markers, including CRP, ESR, and D-dimer; NLR showed a similar profile. Adjustment for age did not materially alter the observed associations. NLR, SII, SIRI, and AISI were higher among children treated with corticosteroids, although discrimination for corticosteroid treatment status was only modest (AUC 0.671-0.704). None of the six indices showed clinically meaningful discrimination for prolonged hospitalization or relapse. Conclusions. The aggregate index of systemic inflammation, systemic inflammation response index, systemic immune-inflammation index, and neutrophil-to-lymphocyte ratio may complement conventional laboratory markers when assessing systemic inflammatory burden in children with rheumatic and systemic inflammatory manifestations following severe acute respiratory syndrome coronavirus 2 infection or exposure. Their modest discrimination for corticosteroid treatment and lack of association with hospitalization duration or relapse do not support their use as standalone clinical decision-making tools. Larger prospective studies are needed.